The purpose of the Act is to improve access to drugs for developing countries that lack the resources to manufacture the drugs and cannot afford to buy them at the usual market cost.
The objective of the legislation is to increase drug availability in impoverished countries where production capabilities are insufficient, and purchasing costs exceed their financial reach.